help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pomerantz, D. K.
Right arrow Articles by Nalbandov, A. V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pomerantz, D. K.
Right arrow Articles by Nalbandov, A. V.

Endocrinology, Vol 96, 558-563, Copyright © 1975 by Endocrine Society

ARTICLES

Acute and chronic estradiol-17beta inhibition of LH release in prepubertal female pigs: time course and site of action

DK Pomerantz, GR Foxcroft and AV Nalbandov

It has been demonstrated that 5.0 mug estradiol-17beta (E2) iv inhibits spontaneous episodic release (SER) of LH from 3-9 h after injection in immature female pigs (gilts). To understand this phenomenon we tested pituitary response (PR) to synthetic LH-RH/FSH-RH (LH-RH) for 13 h after identical E2 treatment in eight 7-8-week-old gilts. Using chronic cannulae PR was determined by measuring the change in plasma LH (delta LH) by RIA after iv injection of 2.0 mug LH-RH. PR was determined every 2 h starting 1 or 2 h before E2 or saline treatments. The PR prior to treatment was 4.3 plus or minus 0.3 ng/ml. By the second releasing- hormone challenge PR in controls was depressed, remaining at about 2.5 ng/ml thereafter. Compared with controls PR depression was greater (P less than 0.005) 1 h following E2 (delta LH = 1.0 plus or minus 0.4 ng/ml). Responsiveness then returned toward pretreatment levels and from 6 h post-treatment onward PR was not different from controls. Initial inhibition of SER may therefore be located in the pituitary and brain. However, after 4 h inhibition appears to be purely neural. Earlier studies showed that subcutaneous (SC) implants of E2 for 3 days in prepubertal gilts depressed PR to LH-RH. We further examined the effect upon PR of implants releasing physiologic levels of E2. PR was evaluated as above at 2-h intervals for 12 h after SC implantation of silastic capsules containing E2 (n = 6) or sham implant (n = 1); then every 6 h up to 54 h post-treatment. For the first 12 h PR depression in the control was identical to controls in the acute experiment; after 36 h PR was similar to pretreatment levels. In E2 implanted animals PR fell to a mean of 1.8 plus or minus 0.1 ng/ml, 4-12 h after implantation, then recovered, stabilizing at 2.3 plus or minus 0.1 ng/ml after 18 h. It is concluded that estrogen treatment rapidly causes a depression of pituitary response to exogenous LH-RH. This rapid effect may not be dependent on E2 dosage. The extent of recovery of pituitary responsiveness probably depends upon the level and persistence of the E2 treatment.




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1975 by The Endocrine Society